Clinical trial
Characterization of the Use of Antipsychotics in PTSD During the Past Seven…
NCT00230893 · Tuscaloosa Research & Education Advancement Corporation, Other · Completed
Key facts
| NCT number | NCT00230893 |
|---|---|
| Title | Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years |
| Official title | Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years |
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | PTSD, Post-Traumatic Stress Disorder |
| Enrollment | 99 |
| Start date | Jul 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Oct 3, 2005 |
| Last update posted | Sep 21, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: